miR-30d inhibits cell biological progression of Ewing's sarcoma by suppressing the MEK/ERK and PI3K/Akt pathways in�vitroConglin Ye(First Affiliated Hospital of Nanchang University), Bin Zhang(City Of Hope National Medical Center)Oncology LettersJanuary 29, 201810.3892/ol.2018.7900Cited by 16SaveCiteExport RISWatch citationsRelated PapersIncidentally cured psoriasis in a patient with refractory/relapsed diffuse large B-cell lymphoma receiving CD19 CAR-T cell therapy: a case report|Frontiers in Immunology|2024|10